Registry Experience at the Washington Hospital Center, DES - Xience V
Status: | Completed |
---|---|
Conditions: | Peripheral Vascular Disease, Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | Any |
Updated: | 2/4/2013 |
Start Date: | August 2009 |
End Date: | June 2012 |
Contact: | Rebecca Torguson |
Email: | rebecca.torguson@medstar.net |
Phone: | 202-877-2194 |
REWARDS (Registry Experience at the Washington Hospital Center, DES - Xience V)
Single center registry of patients who have received a Xience V everolimus-eluting stent at
the Washington Hospital Center, with the primary objective to assess clinical success and
safety at 30 days, 6 months and 1 year post-implantation.
Interventional cardiology was revolutionized by the invention of stents, initially with the
bare-metal stents (BMS) and recently with the drug-eluting stents (DES). The everolimus
eluting, Xience V stents have shown very promising results in randomized clinical trials,
demonstrating a reduction of clinical and angiographic restenosis in comparison to BMS, and
comparable clinically-driven target lesion revascularization rates in comparison with
sirolimus-eluting stents. While registry data is available from outside of the United
States, it will be important to collect "real-world" data regarding the stent usage and
outcomes in the United States. In this study we propose to follow patients who received at
least one Xience V® Stent for at least 1 year post initial stent implantation.
Inclusion Criteria:
- Patients, male or female, >18 years of age
- Patients who received at least one Xience V drug-eluting stent at the Washington
Hospital Center
Exclusion Criteria:
- Patients who received another type of DES (other than Xience V) or a bare metal stent
at the time of initial Xience V stent implantation
We found this trial at
1
site
110 Irving St NW
Washington, District of Columbia 20010
Washington, District of Columbia 20010
(202) 877-7000
Washington Hosp Ctr MedStar Washington Hospital Center is a not-for-profit, 926-bed, major teaching and research...
Click here to add this to my saved trials